Muscle Atrophy clinical trials at University of California Health

1 research study open to eligible people

Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
open to eligible people ages 50-75
An open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
at UC Irvine

Last updated: February 16, 2023